GL1X · GenesisL1 explorer

MolNFT v1 · #76815 · protein

Crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor rygc

3QW6 · Botulinum neurotoxin type a: “Crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor rygc”. X-ray diffraction, 4 ligands (ZN, NA, SO4), 4 pockets (best druggability 0.56). MolNFT v1…

PDB
3QW6
Type
protein
Length
426 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin type a; Inhibitory peptide rygc
EC
3.4.24.69
UniProt
A5HZZ9
Ligands
ZN, NA, SO4, NH2
Pockets
4 · best druggability 0.56

Structure

x-ray diffraction · 2 distinct chains · 31% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin type a (EC 3.4.24.69)protein42231% helix, 18% strandA5HZZ9
BInhibitory peptide rygcprotein40% helix, 0% strand—

Ligands and binding sites

  • ZN · Zinc ion · metal · chains A, B
  • NA · Sodium ion · metal · chains A, B
  • SO4 · Sulfate ion · ion · 3 copies · chains A, B
  • NH2 · Amino group · ion · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12770.560.7745SO4, NA
2810.510.8415empty
3880.340.7523empty
4500.260.7414empty

Interfaces

1 interface between chains.

  • A–B · 486 Ų buried · 17 hydrogen bonds · protein-protein

Compared structures

  • 3QW6 · Crystal structure of the protease domain of Botulinum Neurotoxin Serotype A with a… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.